149 related articles for article (PubMed ID: 29290770)
1. Monocytosis as a prognostic factor for survival in stage IB and IIA cervical cancer.
Eo WK; Kwon BS; Kim KH; Kim HY; Kim HB; Koh SB; Chun S; Ji YI; Lee JY; Namkung J; Kwon S
J Cancer; 2018; 9(1):64-70. PubMed ID: 29290770
[No Abstract] [Full Text] [Related]
2. Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer.
Chen Y; Zhang L; Tian J; Fu X; Ren X; Hao Q
Int J Gynecol Cancer; 2013 Jan; 23(1):157-63. PubMed ID: 23221732
[TBL] [Abstract][Full Text] [Related]
3. Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer.
Eo WK; Jeong DW; Chang HJ; Won KY; Choi SI; Kim SH; Chun SW; Oh YL; Lee TH; Kim YO; Kim KH; Ji YI; Kim A; Kim HY
World J Gastroenterol; 2015 Mar; 21(9):2668-76. PubMed ID: 25759535
[TBL] [Abstract][Full Text] [Related]
4. High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy.
Shigeta K; Kosaka T; Kitano S; Yasumizu Y; Miyazaki Y; Mizuno R; Shinojima T; Kikuchi E; Miyajima A; Tanoguchi H; Hasegawa S; Oya M
Ann Surg Oncol; 2016 Nov; 23(12):4115-4122. PubMed ID: 27364499
[TBL] [Abstract][Full Text] [Related]
5. Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients.
Tadmor T; Bari A; Marcheselli L; Sacchi S; Aviv A; Baldini L; Gobbi PG; Pozzi S; Ferri P; Cox MC; Cascavilla N; Iannitto E; Federico M; Polliack A
Mayo Clin Proc; 2015 Jun; 90(6):756-64. PubMed ID: 26046410
[TBL] [Abstract][Full Text] [Related]
6. [Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy].
Binbin T; Lingying W; Manni H; Jusheng A; Ning L
Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):348-54. PubMed ID: 25030731
[TBL] [Abstract][Full Text] [Related]
7. Vaginal cuff length during radical hysterectomy is a prognostic factor for stage IB-IIA cervical cancer: a retrospective study.
Zuo N; Hu H; Thapa N; Li Z; Jiang D; Meng X; Yang J; Chen X; Cai H
Cancer Manag Res; 2018; 10():5927-5935. PubMed ID: 30510460
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
10. Effect of the Number of Removed Lymph Nodes on Survival in Patients with FIGO Stage IB-IIA Cervical Squamous Cell Carcinoma following Open Radical Hysterectomy with Pelvic Lymphadenectomy: A Retrospective Cohort Study.
Guo Q; Wu Y; Wen H; Ju X; Wu X
J Oncol; 2021; 2021():6201634. PubMed ID: 33936201
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic characteristics and survival analysis in stage IVB cervical cancer with hematogenous metastasis.
Li H; Yang Y; Zhou H; Liu F; Li M; Chen L; Wu X; Cheng X
Transl Cancer Res; 2019 Aug; 8(4):1217-1223. PubMed ID: 35116863
[TBL] [Abstract][Full Text] [Related]
12. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
Singh P; Tripcony L; Nicklin J
Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of preoperative absolute peripheral monocyte count in esophageal squamous cell carcinoma.
Han L; Jia Y; Song Q; Wang N; Wang J; Bai B; Chen X; Wang C; Cheng Y
Dis Esophagus; 2016 Oct; 29(7):740-746. PubMed ID: 26316375
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer.
Onal C; Guler OC; Yildirim BA
Int J Gynecol Cancer; 2016 Jul; 26(6):1169-75. PubMed ID: 27206286
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of adjuvant radiation therapy and prognostic factors in early stage uterine cervical cancer.
Kim HJ; Rhee WJ; Choi SH; Nam EJ; Kim SW; Kim S; Kim YT; Kim GE; Kim YB
Radiat Oncol J; 2015 Jun; 33(2):126-33. PubMed ID: 26157682
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
[TBL] [Abstract][Full Text] [Related]
18. Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study.
Koulis TA; Kornaga EN; Banerjee R; Phan T; Ghatage P; Magliocco AM; Lees-Miller SP; Doll CM
Clin Transl Radiat Oncol; 2017 Jun; 4():51-56. PubMed ID: 29594208
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
Chung HH; Kang SY; Ha S; Kim JW; Park NH; Song YS; Cheon GJ
J Gynecol Oncol; 2016 Mar; 27(2):e15. PubMed ID: 26768781
[TBL] [Abstract][Full Text] [Related]
20. Decreased pretreatment lymphocyte/monocyte ratio is associated with poor prognosis in stage Ib1-IIa cervical cancer patients who undergo radical surgery.
Chen L; Zhang F; Sheng XG; Zhang SQ
Onco Targets Ther; 2015; 8():1355-62. PubMed ID: 26089685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
